loading
전일 마감가:
$1.50
열려 있는:
$1.51
하루 거래량:
255.82K
Relative Volume:
0.12
시가총액:
$4.83M
수익:
$12.99M
순이익/손실:
$-23.72M
주가수익비율:
-0.0151
EPS:
-97.2514
순현금흐름:
$-23.28M
1주 성능:
-8.70%
1개월 성능:
-28.64%
6개월 성능:
-96.94%
1년 성능:
-99.45%
1일 변동 폭
Value
$1.43
$1.5424
1주일 범위
Value
$1.43
$1.60
52주 변동 폭
Value
$1.43
$381.10

Aptevo Therapeutics Inc Stock (APVO) Company Profile

Name
명칭
Aptevo Therapeutics Inc
Name
전화
206-838-0500
Name
주소
2401 4TH AVE., SEATTLE, WA
Name
직원
37
Name
트위터
@aptevo
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
APVO's Discussions on Twitter

APVO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
APVO
Aptevo Therapeutics Inc
1.47 4.93M 12.99M -23.72M -23.28M -97.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
394.53 99.62B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
465.89 61.52B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.00 58.91B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
756.38 46.69B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
324.34 34.54B 3.81B -644.79M -669.77M -6.24

Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2018-11-05 개시 Ladenburg Thalmann Buy
2017-10-05 재개 Piper Jaffray Overweight

Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스

pulisher
Sep 09, 2025

Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - aberdeennews.com

Sep 09, 2025
pulisher
Sep 08, 2025

Is Aptevo Therapeutics Inc. stock trending bullish2025 Top Decliners & Capital Efficient Trading Techniques - classian.co.kr

Sep 08, 2025
pulisher
Sep 06, 2025

Can technical indicators confirm Aptevo Therapeutics Inc.’s reversalJuly 2025 Sentiment & Community Trade Idea Sharing - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Automated trading signals detected on Aptevo Therapeutics Inc.Fed Meeting & Weekly Momentum Picks - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Aptevo Therapeutics Inc. stock daily chart insightsWeekly Market Report & Long Hold Capital Preservation Tips - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is Aptevo Therapeutics Inc. a speculative investmentJuly 2025 Breakouts & High Accuracy Investment Signals - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Does Aptevo Therapeutics Inc. have a sustainable dividendJuly 2025 Price Swings & Comprehensive Market Scan Reports - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Will Aptevo Therapeutics Inc. benefit from sector rotationJuly 2025 Weekly Recap & Daily Oversold Bounce Ideas - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

What is Aptevo Therapeutics Inc.’s book value per shareEarnings Trend Report & Reliable Breakout Stock Forecasts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Can Aptevo Therapeutics Inc. navigate macro headwindsTrade Entry Report & Daily Volume Surge Trade Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Ranking Aptevo Therapeutics Inc. among high performing stocks via toolsPortfolio Return Report & High Accuracy Swing Entry Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Visual analytics tools that track Aptevo Therapeutics Inc. performance2025 Short Interest & Real-Time Volume Triggers - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

With New Cash Aptevo Goes It Alone on Prostate Drug, Shares UpBiotech Movers - TheStreet

Sep 05, 2025
pulisher
Sep 05, 2025

What to do if you’re stuck in Aptevo Therapeutics Inc.Weekly Trade Summary & Low Drawdown Investment Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

News impact scoring models applied to Aptevo Therapeutics Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Aptevo Therapeutics unveils new trispecific immune cell engagers - BioWorld MedTech

Sep 05, 2025
pulisher
Sep 05, 2025

How institutional ownership impacts Aptevo Therapeutics Inc. stockMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Aptevo expands cancer pipeline with two new trispecific therapies By Investing.com - Investing.com Nigeria

Sep 05, 2025
pulisher
Sep 05, 2025

Evaluating Aptevo Therapeutics Inc. with trendline analysisIPO Watch & Target Return Focused Picks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Aptevo Therapeutics Expands Anti-Cancer Pipeline with Patents - MSN

Sep 05, 2025
pulisher
Sep 04, 2025

Is Aptevo Therapeutics Inc. forming bullish engulfing patternsJuly 2025 Final Week & High Conviction Investment Ideas - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Can Aptevo Therapeutics Inc. expand into new marketsMarket Growth Report & Low Drawdown Trading Strategies - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Why Aptevo Therapeutics Inc. is moving todayRecession Risk & AI Based Trade Execution Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What momentum shifts mean for Aptevo Therapeutics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How cyclical is Aptevo Therapeutics Inc.’s revenue streamJuly 2025 Sector Moves & Fast Gaining Stock Reports - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Aptevo expands cancer pipeline with two new trispecific therapies - Investing.com

Sep 04, 2025
pulisher
Sep 04, 2025

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules - ACCESS Newswire

Sep 04, 2025
pulisher
Sep 04, 2025

First-Ever Triple-Action Cancer Therapy: Aptevo's New Trispecifics Target Tumors 3 Ways at Once - Stock Titan

Sep 04, 2025
pulisher
Sep 04, 2025

What is Aptevo Therapeutics Inc. s 5 year growth outlookMarket Movers & Verified Swing Trading Watchlists - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Risk vs reward if holding onto Aptevo Therapeutics Inc.Trade Exit Summary & Technical Confirmation Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Real time social sentiment graph for Aptevo Therapeutics Inc.Buy Signal & Weekly Breakout Opportunity Watchlist - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can volume confirm reversal in Aptevo Therapeutics Inc.July 2025 Catalysts & Reliable Entry Point Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Real time pattern detection on Aptevo Therapeutics Inc. stockEntry Point & Scalable Portfolio Growth Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Using data models to predict Aptevo Therapeutics Inc. stock movementJuly 2025 Sector Moves & Risk Controlled Stock Alerts - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is Aptevo Therapeutics Inc. a defensive stockJuly 2025 Price Swings & AI Driven Price Forecasts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

How to manage a losing position in Aptevo Therapeutics Inc.Profit Target & Daily Technical Forecast Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How moving averages guide Aptevo Therapeutics Inc. trading2025 Technical Patterns & Consistent Income Trade Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Aptevo Therapeutics Inc. currently under institutional pressureJuly 2025 Earnings & Intraday High Probability Setup Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of Aptevo Therapeutics Inc. visualizedGap Down & Real-Time Stock Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will breakout in Aptevo Therapeutics Inc. lead to full recovery2025 Year in Review & Stock Timing and Entry Methods - Newser

Sep 03, 2025

Aptevo Therapeutics Inc (APVO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
자본화:     |  볼륨(24시간):